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Abstract
Study design—Analysis of the State Inpatient Database of North Carolina, 2005–2012, and the 
Nationwide Inpatient Sample, including all inpatient lumbar fusion admissions from non-federal 
hospitals.
Objective—To examine the influence of a major commercial policy change that restricted lumbar 
fusion for certain indications, and to forecast the potential impact if the policy were adopted 
nationally.
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Summary of Background Data—Few studies have examined the effects of recent changes in 
commercial coverage policies that restrict the use of lumbar fusion.
Methods—We included adults undergoing elective lumbar fusion or re-fusion operations in 
North Carolina. We aggregated data into a monthly time series to report changes in the rates and 
volume of lumbar fusion operations for disc herniation or degeneration, spinal stenosis, 
spondylolisthesis, or revision fusions. Time series regression models were used to test for 
significant changes in the use of fusion operation following a major commercial coverage policy 
change initiated on January 1st, 2011.
Results—There was a substantial decline in the use of lumbar fusion for disc herniation or 
degeneration following the policy change on January 1st, 2011. Overall rates of elective lumbar 
fusion operations in North Carolina (per 100,000 residents) increased from 103.2 in 2005 to 120.4 
in 2009, before declining to 101.9 by 2012. The population rate (per 100,000 residents) of fusion 
among those under age 65 increased from 89.5 in 2005 to 101.2 in 2009, followed by a sharp 
decline to 76.8 by 2012. There was no acceleration in the already increasing rate of fusion for 
spinal stenosis, spondylolisthesis or revision procedures, but there was a coincident increase in 
decompression without fusion.
Conclusions—This commercial insurance policy change had its intended effect of reducing 
fusion operations for indications with less evidence of effectiveness without changing rates for 
other indications or resulting in an overall reduction in spine surgery. Nevertheless, broader 
adoption of the policy could significantly reduce the national rates of fusion operations and 
associated costs.
Keywords
Lumbar Spinal Fusion; Degenerative Disc; Disc Herniation; Coverage and Reimbursement; Blue 
Cross Blue Shield of North Carolina
Insurance coverage policies can influence clinical practice and promote appropriate use of 
interventions. Inappropriate use not only adds cost, it can expose patients to potential 
iatrogenic harm without a clear increase in benefit. Questions about appropriate use of 
lumbar fusion in the treatment of low back pain secondary to degenerative disc disease 
prompted the Medicare Coverage Advisory Committee to initiate a review in 2006.[1] Since 
then, payers have increasingly implemented policies that scrutinize use of this procedure.[2, 
3] Broader coverage for lumbar fusion surgery is associated with more frequent use, greater 
use of more complex procedures, higher incidence of surgical complications, and more 
repeat operations.[4] One approach to change practice has been to restrict coverage for 
surgical indications with weaker evidence of effectiveness. However, empirical data are 
lacking on the effects of policy changes on use of lumbar fusion.
There is fairly strong evidence that fusion surgery is effective for some widely-accepted 
surgical indications, such as spondylolisthesis, fractures, and scoliosis.[5, 6] However, for 
degenerative disc disease (DDD), lumbar fusion is controversial, and may not be more 
effective than structured non-operative care.[2, 7, 8] For patients with disc herniation (HNP) 
or spinal stenosis, decompression without fusion is supported by strong evidence, but the 
addition of fusion has not been shown to improve outcomes.[9, 10] For these conditions, 
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fusion surgery often exposes patients to additional surgical complications with little 
advantage over decompression alone.[11–13]
Based on this evidence, the dominant commercial insurer in North Carolina, Blue Cross 
Blue Shield of North Carolina (BCBSNC), initiated a requirement for prior review of lumbar 
fusion procedures on January 1st, 2011, issuing denials of coverage where the sole 
indication was disc herniation (HNP), degenerative disc disease (DDD), stenosis in the 
absence of spondylolisthesis, initial discectomy/laminectomy for neural structure 
decompression, or facet syndrome.[14]
Though not well-suited for studying treatment efficacy, observational studies using 
insurance claims are well suited to measure the effect of healthcare policies because they 
track all patients in a population, wherever they may receive care. Therefore, they are less 
susceptible to selective referral, surveillance bias, reporting bias, and small sample 
variability.
Using statewide discharge databases, we examined trends in lumbar fusion operations, by 
surgical indication, in relation to the policy change implemented on January 1st, 2011 for 
lumbar fusion in North Carolina. When a fusion procedure is not performed, a common 
alternative is a decompression alone, so a policy curtailing fusion surgery might be expected 
to lower overall surgical rates, increase use of decompressions without fusion, or both. We 
expected the use of fusion to decrease for HNP and DDD indications, but wanted to estimate 
the magnitude of this “policy effect” and to forecast the potential impact if such a policy 
were implemented on a national scale. We did not expect to see a similar decrease for 
fusions used with spinal stenosis, an indication more common among older people covered 
by Medicare.
Methods
Data sources
We examined the State Inpatient Database (SID) and State Ambulatory Surgery and Services 
Database (SASD) for North Carolina. The Agency for Healthcare Research and Quality 
(AHRQ) maintains SID and SASD, which are components of the Healthcare Cost and 
Utilization Project (HCUP).[15] Data from HCUP has previously been used to study spinal 
procedures.[16–20] Variables provided by these all-payer inpatient (SID) and ambulatory 
(SASD) discharge registries include diagnosis and procedure codes, patient demographics, 
and charges from non-federal hospitals and from hospital-owned and freestanding 
ambulatory surgical and outpatient surgery facilities. Up to 33 diagnosis and 24 procedures 
codes from the International Classification of Diseases, 9th revision, Clinical Modification 
(ICD-9-CM), are listed with each discharge summary in SID; and each SASD visit summary 
contains up to 30 procedure codes from the American Medical Association’s Current 
Procedural Terminology (CPT) and up to 33 ICD-9-CM diagnosis codes. Sex- and age-
stratified (by 5-year increments) population datum specific to North Carolina, available from 
the U.S. Census, were used as a denominator for deriving statewide procedure rates. 
National population data were applied to derive national rate estimates.[21] Hospital cost-to-
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charge ratios were obtained from HCUP to estimate the trends in aggregated costs for spinal 
admissions over time.
The 2005–2012 National Inpatient Sample (NIS), available through AHRQ, was used to 
estimate the potential impact of a broader implementation of a non-coverage policy on a 
national scale. The National Inpatient Sample is a nationally representative sample of 
discharge summaries from non-federal hospitals in the United States commonly used to 
track trends in inpatient procedures. As with the state data, participating hospitals submit 
uniform patient demographics, discharge disposition, hospital charges, and diagnosis and 
procedure codes to AHRQ’s central distributor. Survey weighting and sampling design 
variables are included with the data to produce national estimates of utilization. We applied 
the revised 2012 longitudinal weights created for trend analyses.
Study population
We identified adults (age 20 or older) who had a thoracolumbar, lumbar, or lumbosacral 
fusion for degenerative spinal conditions in North Carolina from 2005 through 2012. We 
included all fusion operations reported by non-Federal facilities in North Carolina (n = 
57,813), including 2,360 (4.1%) that derived from the ambulatory database (SASD). Patients 
were selected using a validated algorithm based on ICD-9-CM and CPT diagnosis and 
procedure codes, with 98% sensitivity and 99.1% specificity for correctly identifying fusion 
cases.[22, 23]
We excluded patients with non-degenerative spinal pathology such as vertebral fractures, 
spinal cord injury, intraspinal abscess, or inflammatory spondylopathy. We also excluded 
patients with admissions coded for accidents, neoplasm, immune deficiency, osteomyelitis, 
and cervical or thoracic procedures. Lumbar fusion operations combined with 
decompressions were included, as were patients with codes implying previous spine 
operation (e.g., “refusion”). However, patients undergoing artificial disc replacement, 
corpectomy, osteotomy, or kyphectomy were excluded. Admissions involving an insertion of 
spinal spacers or dynamic stabilizing devices were only included if co-coded with a fusion 
operation.
Classifying surgical indications
All diagnosis and procedure codes available for each admission were used to designate 
surgical indication. This was accomplished by using a previously published hierarchical 
coding algorithm, grouping cases as: revision spine operations (top of hierarchy), scoliosis, 
spondylolisthesis, stenosis, disc herniation (with and without myelopathy), and disc 
degeneration (e.g. spondylosis).[22] Admissions for disc herniation or degenerative disc 
disease were combined into a common variable since these were the primary indications 
targeted by the policy restriction. To further simplify the presentation, we also combined 
admissions related to spondylolisthesis or scoliosis.
Decompression procedures
We examined combined trends for laminectomy, laminotomy, and discectomy procedures 
(herein “decompression without fusion”) in North Carolina over the same period. For this 
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analysis, we included all inpatient admissions and outpatient operations for decompression 
without fusion, but otherwise applied the same inclusion and exclusion criteria used to 
define the fusion cohort.
Covariates
Because changes in patient characteristics could explain changes in fusion (and 
decompression) procedure rates over time, we described changes in age, sex, comorbidity, 
previous surgery, and surgical indication in our cohorts. An “enhanced” version of the 
Charlson index was used to measure comorbidity, grouped as “none”, “one”, or “two or 
more”.[24]
Costs
Trends in the hospital costs for inpatient fusion operations excluded professional fees and 
non-covered services. The medical component of the Consumer Price Index was used to 
adjust costs from earlier years to their 2012 equivalents.[25]
Analysis
Differences in patient characteristics, comorbidity, diagnoses, and operative features were 
summarized, with chi-square or t-test comparisons between the years before and after the 
policy change was implemented on January 1st, 2011.
We then aggregated the volume of fusion procedures into a monthly time series. A 
smoothing function was used to examine trends in the crude (unadjusted) rates and volume 
of fusion operations over time. To test whether there was a significant change in using fusion 
after the policy was implemented, we used Autoregressive Integrated Moving Average 
(ARIMA) adjusting for the monthly proportional changes in the distributions of sex, mean 
age, and mean comorbidity index. An ARIMA is a regression model for time series data that 
incorporates both a smoothing function to eliminate idiosyncratic variability (“moving 
average”) and a function to improve the estimate for each month based on its correlation 
with the estimate from the previous month (“auto-regressive” component). The outcomes for 
our models were the month-to-month change (i.e. the first difference) in the rate and volume 
of lumbar fusion operations, adjusting for the monthly proportional change in mean age, 
percent female, and mean comorbidity. To understand the policy effect, we separately 
documented changes in procedure rates by surgical indication and by insurance type (public 
and private payers). We also examined whether there was a coincident increase in use of 
decompression without fusion. Hypothesis testing was based on significance of the 
difference in the regression coefficient for each outcome before-versus-after implementation 
of the policy on January 1st, 2011, using a two-sided alpha level of 0.05.
Mean admission costs were estimated using generalized linear regressions, adjusting for age, 
sex, comorbidity, previous surgery, and diagnosis.
We applied the “policy effect” from North Carolina to the observed fusion operation rates in 
the Nationwide Inpatient Sample in order to estimate the potential impact of a national 
policy change. The estimated “policy effect” from North Carolina is the indication-specific 
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ratio of the observed fusion volume to the expected volume if there were no change in the 
coverage policy, estimated by forecasting the monthly pre-policy trend through 2014. The 
ratio of observed-to-expected volume serves as a measure of the potential “policy effect”. 
Applying this ratio to the national data allowed us to estimate the number of fusion 
operations that might have been avoided by a national policy change, along with associated 
hospital costs reduction. Separate estimates were created for only those over age 65 and 
based on whether decompression without fusion serves as a substitute procedure.
All analyses were performed using StataMP, version 13 (College Station, TX). A waiver of 
human subjects review for publicly available data was obtained from the Committee for the 
Protection of Human Subjects at Dartmouth College.
Results
Study population
We identified 67,783 lumbar spinal fusion operations for degenerative or revision diagnoses 
in North Carolina from 2005 through 2012. We excluded 9,970 procedures (14.7%; Table 1), 
leaving 57,813 eligible, including 11,145 (19.3%) for patients who had a previous lumbar 
spine operation.
NC Policy Effect
We observed marked differences in rates and volume of fusion operations in North Carolina 
following the January 1, 2011 implementation of the policy change (Figure 1). The 
annualized age-, sex-, and comorbidity-adjusted rate of lumbar fusion (all indications) per 
100,000 residents of North Carolina increased from 103.2 in 2005 (6,173 fusion procedures) 
to a peak of 120.4 in 2009 (8,189 fusion procedures), before decreasing to 101.9 (7,555 
fusion procedures) in 2012. The volume of fusion operations increased, on average, by 36 
cases per year prior to the policy change. This was followed by a decrease of 94 cases per 
year after the policy was implemented (p<0.001).
In contrast to the trends for fusion surgery, the rate of lumbar decompression significantly 
increased in North Carolina following the policy change on January 1st, 2011 (Figure 1, 
p=0.004). In absolute volume, the increase in decompression was approximately equivalent 
to the decrease of fusion operations. The annualized population rate of decompression 
procedures in North Carolina decreased from 185.9/100,000 in 2005 (11,265 procedures) to 
144.1/100,000 (10103 procedures) in 2010, followed by an increase to 150.7/100,000 
(10973 procedures) in 2012.
The decrease in lumbar fusion combined with the corresponding increase in decompression 
without fusion resulted in an overall slight decrease in the rates of spine surgery that did not 
achieve statistical significance (p = 0.346; table 3).
The mean age of patients undergoing lumbar fusion following the initiation of the policy 
change was 58.7 years, compared to 55.9 among those in the previous years (Table 2, p < 
0.001). There was no pre-post difference in the distribution of sex (p=0.560). There was a 
slightly, but statistically significantly, greater proportion of Blacks and Asians undergoing 
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fusion surgery in the years following the policy change (p=<0.001). Patients undergoing 
fusion operations after the initiation of the policy had more comorbidity (p=0.001) and were 
more likely to be receiving public insurance (p=<0.001), compared to those before the 
policy change.
A smaller proportion of fusion admissions after the policy change was initiated had a length 
of stay of four or more days (Table 2). In addition, the proportion of fusion operations 
involving combined surgical approaches, stabilizing instrumentation, and 4 or more 
vertebrae (3 or more disc levels) were all slightly greater after initiation of the policy change. 
Use of Bone Morphogenetic Protein was lower in the post policy period than in the pre-
policy period.
Changes in the volume of fusion operation following the policy change varied by surgical 
indication (Figure 2). Table 3 provides the corresponding results of the ARIMA time-series 
regression models. Separate fusion models were estimated for each surgical indication. The 
beta coefficients for each parameter represent the average monthly change in volume, 
controlling for other factors included in the model. For example, a one percent increase in 
the proportion of females undergoing a fusion is associated with one additional lumbar 
fusion of any diagnosis per month (coef 1.047, not significant). The change in the monthly 
volume of fusions (any diagnosis) decreased by nearly 8 procedures per month after the 
policy change was initiated (coef −7.86, p<0.001). After controlling for age, sex and 
comorbidity, there was a significant decrease in fusion for HNP or DDD following the non-
coverage policy (p<0.001). The policy effect was similar for these two surgical indications. 
On average, fusions procedures for these indications increased by 11 cases per year prior to 
the policy change, followed by a decrease of 71 cases per year following the policy. There 
was no change in fusion rates for spinal stenosis, revisions operations, or spondylolisthesis 
and scoliosis (combined) following the policy change.
By 2012, a greater volume of fusion operations was being performed among publicly 
insured patients. While the annualized population rate of fusion increased among those 65 or 
older, from 168.1/100,000 in 2005 to 221.0/100,000 in 2012, the rate decreased among those 
under age 65, from 89.5/100,000 in 2005 to 76.8/100,000 in 2012 (after peaking at 
101.2/100,000 in 2009). Trends in the use of fusion following the policy change were more 
pronounced for those covered by commercial insurers than those covered by public insurers 
(Figure 3). In addition, the decrease in fusion operations following the initiation of the 
policy was slightly more pronounced among those covered by BCBSNC than those covered 
by other commercial policies.
Hospital cost
The reduction in the volume of fusion operations in North Carolina following the policy 
change resulted in a significant decrease in the trends in aggregate hospital costs (Figure 4). 
Prior to the January 1st, 2011 policy change, the total annual hospital costs for fusion 
operations in North Carolina increased 96%, from $149.7 Million in 2005 to $292.7 Million 
in 2010. Hospital cost then decreased in 2011 before stabilizing by 2012.
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Estimated National Policy Impact
In examining U.S. trends from the National Inpatient Sample, we found that following 
several years of steady increases, the population rates of fusion surgery for HNP and DDD 
in the United States have decreased since 2010 (Figure 5). The estimated impact of a policy 
change if scaled to a national level, shown in Figure 5, displays both the observed and 
hypothetical “expanded policy” trends in the United States. A policy adopted on January 1, 
2011 might have resulted in 3,712 fewer fusion operations by the end of 2013 (Table 4). If 
the policy change were scaled to a national level, we estimate a potential hospital cost 
reduction of $270 Million during the first three years (or $185 million if decompression 
procedures increased proportionally). This represents approximately 3% of total hospital 
costs for elective fusion.
Discussion
Lumbar fusion operations for HNP or DDD indications decreased precipitously in North 
Carolina following the initiation of a commercial policy change that targeted these select 
indications. While there was no evidence of acceleration in the ongoing rise of fusions for 
spondylolisthesis, scoliosis, or spinal stenosis, there was a concomitant increase in 
decompression without fusion during the study period. The overall effect of these trends was 
a slight, non-significant, decrease in overall volume of spine operations.
Decreasing rates of lumbar fusion operations for HNP or DDD, without a commensurate 
increase for other indications, suggests that the policy change had its intended effect of 
reducing the use of fusion for these indications. The effect of the policy change on fusion 
operations was greater among those covered by commercial insurers than for those covered 
by public insurance, and greater for those covered by BCBSNC than for other commercial 
insurers. From a payer perspective, the policy change had its intended effect of increasing 
the proportion of fusion procedures performed for indications supported by stronger 
evidence. Broader adoption of the policy targeting select indications could significantly 
reduce the national rates of inpatient fusion admissions and corresponding hospital costs, 
even if decompression without fusion simultaneously increased.
While we observed a clear reduction in the use of fusion surgery for HNP and DDD, the lack 
of change in the use of fusion surgery for spinal stenosis may be because stenosis is more 
common in an older, publicly insured population, or because of diagnostic overlap between 
stenosis and spondlylolisthesis.
We used population-based data to document the effects of a policy change that targets the 
use of fusion operations for selected indications. Our longitudinal study complements 
previous cross-sectional comparisons that have found similar coverage and reimbursement 
policies to be influential, explaining a large proportion of practice variation in fusion 
operations.[4] The BCBSNC policy change covers fusions that it defines as “medically 
necessary” and instituted an appeal process for non-covered fusions. Some have argued that 
the development of this policy was not transparent and that it failed to cite clinical evidence 
to support the coverage decision.[26] However, the new policy is similar to that previously 
initiated in Washington State, which has had similar effects.
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Our findings have several limitations. Our analysis only shows a decrease in utilization of 
fusion, and does not provide any information on outcomes for patients. Because HCUP data 
do not enable us to identify patients who were either denied a fusion or were never 
considered for fusion as a consequence of the policy change, we cannot know what 
alternative treatment(s) they received. HCUP data lack clinical detail such as patient 
reported pain and function, image findings, and specific vertebral level(s) operated on. 
Future comparative effectiveness and policy research is needed to consider the clinical 
implications and patient-reported outcomes among patients undergoing spinal operations. Of 
particular interest is the need to document the rate at which these patients have additional 
operations. Additional operations could potentially lessen the long-term cost savings, 
although the rates of reoperation following an initial fusion appear higher than 
decompression alone, and are more costly. Our reliance on an observational research design 
precludes a direct inference that the changes in use of fusion operation for HNP and DDD 
were caused by the policy change, or that decompression without fusion served as a 
substitute procedure. Factors other than the implementation of the policy could have driven 
the changes we observed, although this seems unlikely given the specificity of the effect on 
targeted surgical indications and the specific insurance carrier that implemented the policy 
change. It is also unlikely there was a sudden change in the underlying pathology of patients 
undergoing spinal operations coincident with the initiation of the policy change, especially 
given several preceding years of stable increases in volume.
Insurers have increasingly initiated policies intended to reduce the use of lumbar fusion for 
disc herniation and degenerative disc disease.[14, 27] From a payer perspective, these 
policies appear to have the intended effect of making the use of lumbar fusion more 
concordant with clinical evidence, but did not reduce the overall rate of lumbar spine surgery 
or potential “overuse” of surgery in general. Despite an initial decrease, hospital costs for 
fusion started to increase again in 2012. Longer term data are necessary to determine 
whether the policy effect on procedure rates and cost will be sustained.
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Figure #1. 
Monthly trends in volume of lumbar spine surgery in North Carolina, before and after 
commercial coverage policy change.
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Figure #2. 
Monthly trend in volume of lumbar fusion surgery in North Carolina by surgical indication, 
before and after commercial coverage policy change.
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Figure #3. 
Monthly trend in volume of lumbar fusion surgery in North Carolina by insurance type, 
before and after commercial coverage policy change.
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Figure #4. 
Monthly trend in hospital costs for spine surgery in North Carolina by type of surgery, 
before and after commercial coverage policy change.
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Figure #5. 
Monthly trends in volume of fusion for disc herniation or decompression in the United 
States, with possible effects of expanding the policy change
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Table 1
Inclusion and exclusion summary
Pre Policy Post Policy All
Included admissions
  Lumbar fusion for degeneration or revision diagnosis 49610 18173 67783
Excluded Diagnosis
  Fracture or dislocation 1787 782 2569
  Spinal Cord Injury 88 57 145
  congenital or other anomaly 2074 1146 3220
  Inflammatory spondylopathy 112 90 202
Excluded Procedures
  Artificial disc replacement 152 37 189
  Open treatment of fracture 458 212 670
Excluded Comorbidity
  Cancer 471 231 702
  Neurological impairment 214 194 408
  Immune deficiency 50 37 87
  Intraspinal Abscess 75 53 128
  Osteomyelitis 175 94 269
  Pregnancy * * *
Other exclusions
  Trauma 383 167 550
  Drug abuse 79 37 116
  Age under 20 years 2081 757 2838
Summary Inclusion and Exclusion
  All inclusion criteria 49610 18173 67783
  Any exclusion 6823 3147 9970
  Final cohort size 42787 15026 57813
Source: Agency for Healthcare Research & Quality’s SID and SASD from North Carolina, 2005–2012.
Pre and post-policy periods defined by policy initiated on January 1st, 2011.
*
values suppressed based on reporting guidelines for tables with cell counts <= 10 cases
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Table 2
Sample characteristics
Pre Policy Post Policy All p-value
Age
  Age (mean) 55.9 58.7 56.6 <0.001
  Age 20 to 65 (%) 70.3 62.5 68.2 <0.001
  Age 65 or older (%) 29.7 37.5 31.8
Sex
  Male (%) 41.1 40.8 41.0 0.560
  Female (%) 58.9 59.2 59.0
Race
  White (%) 86.4 84.9 85.9 <0.001
  Black (%) 10.7 12.8 11.5
  Asian (%) 0.2 0.8 0.5
  Other or Multiple (%) 2.6 1.5 2.2
Comorbidity
  None (%) 65.0 60.9 64.0 <0.001
  One (%) 26.7 27.6 26.9
  Two or more (%) 8.2 11.5 9.1
Insurance
  Medicare (%) 34.3 41.5 36.2 <0.001
  Medicaid (%) 6.9 6.9 6.9
  Commercial (%) 48.0 43.2 46.8
  Other or uninsured (%) 10.8 8.3 10.1
Length of stay
  One day (%) 10.1 10.7 10.3 <0.001
  Two days (%) 12.8 16.7 13.8
  Three days (%) 26.0 27.3 26.3
  Four days (%) 22.1 19.5 21.5
  Five or more days (%) 29.0 25.9 28.2
Diagnosis
  Disc herniation or degeneration (%) 43.1 30.9 39.9 <0.001
  Stenosis (%) 16.5 19.2 17.2
  Spondylolisthesis or scoliosis (%) 38.8 48.2 41.3
  Revision without other diagnosis (%) 1.6 1.8 1.6
Operative characteristics
  Combined surgical approach (%) 13.1 15.7 13.8 <0.001
  Stabilizing instrumentation (%) 62.1 68.0 63.7 <0.001
  Bone morphogenetic Proteins (%) 29.1 21.4 27.1 <0.001
  3+ disc levels fused (%) 17.1 18.8 17.5 <0.001
Source: Agency for Healthcare Research & Quality’s SID and SASD from North Carolina, 2005–2012.
Pre and post-policy periods defined by policy initiated on January 1st, 2011.
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Table 4
Potential effect of an expanded policy in terms of reduced lumbar fusion operations and hospital costs.
Scope of expanded policy change Year N reduced
Cost reduction
from fusion
Cost reduction with
replaced by decompression
Applied nationally 2011 580 41.7 M 28.2 M
2012 1414 102 M 70.0 M
2013 1719 126 M 87.0 M
3-years combined 3712 270 M 185 M
Applied to Medicare only 2011 216 16.9 M 11.4 M
2012 534 40.8 M 27.9 M
2013 661 49.0 M 33.9 M
3-years combined 1410 107 M 73.2 M
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